The 'Onzetra Xsail' is a revolutionary device that may provide relief for millions of migraine sufferers. There are approximately 37 million Americans who suffer from migraines and a number of these individuals get them on a daily basis. But now there is a new device that could alleviate the suffering of these individuals.
The Onzetra Xsail is an inhaler that contains the prescription drug sumatriptan, which is currently used to treat migraines. Unlike the pills containing sumatriptan, the inhaler delivers 80 percent less medication. This is because oral treatments need to be absorbed through the stomach lining, while an inhaler can send medication directly into the bloodstream via the mucous membrane of the sinus cavity. As a result, using the inhaler can help migraine sufferers avoid the nausea that often comes from taking sumatriptan pills.
Although the Onzetra Xsail is still awaiting FDA approval, the new migraine inhaler could provide a viable alternative to oral migraine medication.
Migraine-Alleviating Inhalers
This Inhaler is Designed to Provide Relief for Migraine Sufferers
Trend Themes
1. Migraine Inhalers - The development of low dosage inhalers for treating migraines can revolutionize the way people get relief from migraines.
2. Mucous Membrane Delivery Systems - The development of direct-to-bloodstream delivery systems for medication administration can make treatment of health conditions faster and more efficient.
3. Fda-approved Non-oral Medication Delivery - The rise of non-oral medication delivery systems, such as inhalers, can provide safe and efficient alternatives to traditional oral medications.
Industry Implications
1. Pharmaceuticals - Pharmaceutical companies can invest in developing novel drug delivery systems, such as inhalers, to capture a larger share of the migraine medication market and to meet the growing demand for non-oral medications.
2. Medical Devices - Medical equipment manufacturers can develop inhalers and other devices that employ non-traditional delivery methods, like mucous membrane delivery, to target health conditions and offer patients alternative treatment methods.
3. Healthcare Services - Healthcare services providers can partner with pharmaceutical companies and medical equipment manufacturers to offer innovative and efficient non-oral medication delivery options to their patients and customers.